{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "the-joint-commission", "type": "clause", "offset": [15, 35]}], "size": 10, "snippet": "or \"TJC\" means the Joint Commission.", "samples": [{"hash": "l5bmk6Vc8sz", "uri": "https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/policy/provider-certification/administrative-rules/2024/PC--Chapter-70_10-30-24.pdf", "label": "oklahoma.gov", "score": 18.5417003632, "published": false}, {"hash": "7vdZdRVvgJZ", "uri": "https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/policy/provider-certification/administrative-rules/2023/PC--Chapter-70-Final-effective-9-15-23.pdf", "label": "oklahoma.gov", "score": 10.826830864, "published": false}, {"hash": "eZpYTQK5oJH", "uri": "https://oklahoma.gov/content/dam/ok/en/odmhsas/documents/policy/provider-certification/administrative-rules/2022/Chapter%2070%20Final%20effective%209-15-22%20w%20History.pdf", "label": "oklahoma.gov", "score": 10.3490762711, "published": false}], "hash": "6c5cb9099e9d22eb123b196a5bfafb61", "id": 1}, {"snippet_links": [], "size": 6, "snippet": "has the meaning set forth in Section 2.4(i).", "samples": [{"hash": "aaTahls5VWP", "uri": "/contracts/aaTahls5VWP#jc", "label": "License Agreement (Pelthos Therapeutics Inc.)", "score": 36.7070503235, "published": true}, {"hash": "kI7sh5XSOx7", "uri": "/contracts/kI7sh5XSOx7#jc", "label": "License Agreement (Novan, Inc.)", "score": 34.2402458191, "published": true}, {"hash": "kyIvKxomnTQ", "uri": "/contracts/kyIvKxomnTQ#jc", "label": "License Agreement (Novan, Inc.)", "score": 28.2142372131, "published": true}], "hash": "50b84ccdc3bc326abe6f6e60cfc570d8", "id": 2}, {"snippet_links": [{"key": "the-joint-commission", "type": "clause", "offset": [6, 26]}], "size": 4, "snippet": "means the Joint Commission.", "samples": [{"hash": "ijvqdggkOCw", "uri": "/contracts/ijvqdggkOCw#jc", "label": "Dip Credit Agreement", "score": 23.7624912262, "published": true}, {"hash": "jXgkRL3F4p1", "uri": "https://casedocs.omniagentsolutions.com/cmsvol2/pub_47346/760844_557.pdf", "label": "casedocs.omniagentsolutions.com", "score": 9.8199863434, "published": false}, {"hash": "8LSiBPmMcOh", "uri": "https://casedocs.omniagentsolutions.com/cmsvol2/pub_47346/750487_166.pdf", "label": "casedocs.omniagentsolutions.com", "score": 9.7624912262, "published": false}], "hash": "1776a7458e6072a2424841ef334f10c2", "id": 3}, {"snippet_links": [], "size": 3, "snippet": "means JenCap UX and/or its Affiliates.", "samples": [{"hash": "5ciMnOZGI59", "uri": "https://www.sec.gov/Archives/edgar/data/1729173/000104746918004217/a2235892zex-3_1.htm", "label": "Uxin LTD", "score": 11.4134159088, "published": false}, {"hash": "5lFEvptFygg", "uri": "https://www.sec.gov/Archives/edgar/data/1729173/000104746918004128/a2235772zex-3_1.htm", "label": "Uxin LTD", "score": 11.4052019119, "published": false}, {"hash": "ehAxOCTWj7d", "uri": "https://www.sec.gov/Archives/edgar/data/1729173/000091205718000149/filename2.htm", "label": "Uxin LTD", "score": 11.2217655182, "published": false}], "hash": "8cd77474749ab9e41cbec844ae9a4450", "id": 4}, {"snippet_links": [{"key": "the-committee", "type": "clause", "offset": [6, 19]}, {"key": "by-the-parties", "type": "clause", "offset": [27, 41]}], "size": 3, "snippet": "means the committee formed by the Parties as described in Section 3.1(a).", "samples": [{"hash": "jI99aQtPFmS", "uri": "/contracts/jI99aQtPFmS#jc", "label": "Option and License Agreement (Bavarian Nordic a/S / ADR)", "score": 27.0287475586, "published": true}, {"hash": "dSX50AVcRkN", "uri": "/contracts/dSX50AVcRkN#jc", "label": "Option and License Agreement (Bavarian Nordic a/S / ADR)", "score": 27.0068454742, "published": true}, {"hash": "i83DCPzMfAC", "uri": "/contracts/i83DCPzMfAC#jc", "label": "Option and License Agreement (Bavarian Nordic a/S / ADR)", "score": 26.856262207, "published": true}], "hash": "4fc7516d32c4eaa1756d6563d65ba236", "id": 5}, {"snippet_links": [{"key": "joint-committee", "type": "clause", "offset": [4, 19]}, {"key": "major-market-countries", "type": "definition", "offset": [61, 83]}, {"key": "net-sales", "type": "definition", "offset": [126, 135]}, {"key": "other-indications", "type": "definition", "offset": [192, 209]}, {"key": "product-samples", "type": "clause", "offset": [390, 405]}], "size": 2, "snippet": "or \"Joint Committee\" .............................. 11 1.37 \"Major Market Countries\"................................ 11 1.38 \"Net Sales\".............................................. 12 1.39 \"Other Indications\"...................................... 12 1.40 \"Patents\"................................................ 12 1.41 \"Product\"................................................ 12 1.42 \"Product Samples\"........................................ 13 1.43 \"Projected Global Tracked Sales\"......................... 13", "samples": [{"hash": "jRd6w54KHay", "uri": "/contracts/jRd6w54KHay#jc", "label": "Collaboration and Promotion Agreement (Aspreva Pharmaceuticals CORP)", "score": 18.0, "published": true}, {"hash": "bk6ZPNYeD0k", "uri": "/contracts/bk6ZPNYeD0k#jc", "label": "Collaboration and Promotion Agreement (Aspreva Pharmaceuticals CORP)", "score": 18.0, "published": true}], "hash": "e64a04e767bda16cb6fc5aca6188f586", "id": 6}, {"snippet_links": [{"key": "company-limited", "type": "clause", "offset": [27, 42]}, {"key": "validly-existing", "type": "clause", "offset": [74, 90]}, {"key": "cayman-islands", "type": "definition", "offset": [101, 115]}, {"key": "registered-office", "type": "definition", "offset": [125, 142]}], "size": 2, "snippet": "means JenCap UX, a private company limited by shares duly established and validly existing under the Cayman Islands with its registered office located at \u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, Grand Cayman, KY1-1104, Cayman Islands, and/or its Affiliates.", "samples": [{"hash": "jGQNzQIYANX", "uri": "/contracts/jGQNzQIYANX#jc", "label": "Shareholder Agreement (Uxin LTD)", "score": 27.4052028656, "published": true}, {"hash": "1FyLFEC7o81", "uri": "/contracts/1FyLFEC7o81#jc", "label": "Shareholder Agreement (Uxin LTD)", "score": 27.3367557526, "published": true}], "hash": "3c5460945fa51bb949e90a49ac159831", "id": 7}, {"snippet_links": [{"key": "joint-committee", "type": "clause", "offset": [4, 19]}, {"key": "section-31", "type": "definition", "offset": [57, 68]}], "size": 2, "snippet": "OR \"JOINT COMMITTEE\" shall have the meaning set forth in Section 3.1.", "samples": [{"hash": "jRd6w54KHay", "uri": "/contracts/jRd6w54KHay#jc", "label": "Collaboration and Promotion Agreement (Aspreva Pharmaceuticals CORP)", "score": 18.0, "published": true}, {"hash": "bk6ZPNYeD0k", "uri": "/contracts/bk6ZPNYeD0k#jc", "label": "Collaboration and Promotion Agreement (Aspreva Pharmaceuticals CORP)", "score": 18.0, "published": true}], "hash": "9bc0fb78bc8cce95d65624477f1a53f0", "id": 8}, {"snippet_links": [{"key": "service-operator", "type": "definition", "offset": [8, 24]}, {"key": "the-operator", "type": "clause", "offset": [32, 44]}, {"key": "network-operator", "type": "definition", "offset": [88, 104]}, {"key": "core-network", "type": "clause", "offset": [129, 141]}, {"key": "parts-of-the", "type": "clause", "offset": [229, 241]}, {"key": "access-network", "type": "clause", "offset": [242, 256]}, {"key": "other-networks", "type": "clause", "offset": [272, 286]}], "size": 2, "snippet": "Network Service Operator\u201d means the operator defined under the Unified License (Virtual Network Operator) which owns the telecom core network and provides core network service to the Virtual Network Operator to connect different parts of the access network and gateway to other networks;\u201d;", "samples": [{"hash": "5W3RjaCitoW", "uri": "https://www.trai.gov.in/sites/default/files/RegulationsMNPEng13122018.pdf", "label": "www.trai.gov.in", "score": 7.4736480713, "published": false}], "hash": "120dcf0d5d4b12a0c352dfb1b07ff62e", "id": 9}, {"snippet_links": [], "size": 1, "snippet": "means Jason Cremona.", "samples": [{"hash": "lWwR8UMOM4a", "uri": "https://www.rccol.vic.gov.au/sites/default/files/2021-08/Transcript%20of%202%20July%202021%20(Williamson).pdf", "label": "www.rccol.vic.gov.au", "score": 6.7823410034, "published": false}], "hash": "5d85dd080702b1ffbeea18bca8169be8", "id": 10}], "next_curs": "Ck8SSWoVc35sYXdpbnNpZGVyY29udHJhY3RzcisLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiILamMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 44, "title": "JC", "snippet": "or \"TJC\" means the Joint Commission.", "id": "jc", "examples": ["Each Party shall bear all the expenses of its representatives on the <strong>JC</strong>.", "For the first [***] following the Effective Date, a <strong>JC</strong> member appointed by Novan shall serve as chairperson of the <strong>JC</strong>.", "If the <strong>JC</strong> determines that such Pre-Clinical Studies should be repeated (such repeated Pre-Clinical Studies, the \u201cRepeat Studies\u201d), Novan shall perform such Repeat Studies at Novan\u2019s expense, provided that in no event shall Novan be required to spend more than one million ($1,000,000) USD with regard to all Repeat Studies in the aggregate.", "The <strong>JC</strong> shall oversee the research, development, and commercialization of the Licensed Products in the Licensed Territory.", "The <strong>JC</strong> will coordinate communications regarding certain aspects of the Parties\u2019 marketing efforts for Licensed Product in the Licensed Field as follows.", "Each Party may replace its <strong>JC</strong> representatives by written notice to the other Party.", "Within [***] after the completion of the PMDA consultation described in Section 4.1, S\u2587\u2587\u2587 shall submit a development plan (\u201cDevelopment Plan\u201d) to the <strong>JC</strong> for review and approval.", "In the event that the PMDA determines, as documented in official, written correspondence with S\u2587\u2587\u2587, that the applicable Pre-Clinical Studies are not sufficient for approval of the JNDA, then the <strong>JC</strong> shall decide whether the applicable Pre-Clinical Studies should be repeated.", "The location of the meetings of the <strong>JC</strong> to be held in person shall be agreed upon by the Parties.", "The <strong>JC</strong> shall meet at least once every [***] prior to the First Commercial Sale of the Licensed Product in the Licensed Field in the Licensed Territory and at least [***] every year thereafter, in each case at times mutually agreed upon by the Parties."], "related": [["public-schools", "Public schools", "Public schools"], ["public-school", "Public school", "Public school"], ["nhs", "NHS", "NHS"], ["microenterprise", "Microenterprise", "Microenterprise"], ["tsc", "TSC", "TSC"]], "related_snippets": [], "updated": "2026-05-03T04:25:59+00:00"}, "json": true, "cursor": ""}}